accountcould take in more than $200 million more through a new partnership with Eisai Co. MPM, along with Kleiner Perkins Caufield & Byers, co-led Epizyme?s $14 million Series A in February 2008. Lucrative partnerships like these come from having early and...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Biotech VCs Figuring Out How To Roll With The Punches
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account